FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for clarithromycin by Sandoz Inc., confirming the approval of a generic clarithromycin product under ANDA 065283.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Helicobacter Pylori Infection
• Otitis Media
• Peptic Ulcer Disease
• Skin and Skin Structure Infections

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

SUPPL AP for CLARITHROMYCIN (CLARITHROMYCIN)